Antitrust
-
Regulation
DraftKings, FanDuel Focused in Senators’ Antitrust Push
DraftKings (NASDAQ: DKNG) and FanDuel are drawing bipartisan accusations of collusive habits that might violate US antitrust legal guidelines. The…
Read More » -
Regulation
Customary Normal Bally’s Deal Unlikely to Face Antitrust Threats
Customary Normal’s proposed $18.25 per share takeover of Bally’s (NYSE: BALY) seems unlikely to face antitrust scrutiny from federal regulators…
Read More »